Dermatology Flashcards
features of eczema
defects in the skin barrier lead to inflammation
- redness
- itch
- dry
- FHx
- flexor surfaces common (cheeks in children)
endogenous types of eczema
varicose eczema
seborrheic dermatitis
discoid eczema
atopic eczema
signs of bacterial infection of eczema
management
weeping, pustules, crusts, atopic eczema failing to respond to therapy, rapidly worsening atopic eczema, fever and malaise)
Fucidin H Cream applied topically if milder
Oral Abx such as fluclox if more severe
eczema herpeticum
a viral infection of eczema involving herpes simplex virus 1 or 2
signs:
- areas of rapidly worsening, painful eczema
- clustered blisters consistent with early-stage cold sores
- punched-out erosions
- fever, lethargy or distress.
needs admission and IV aciclovir
treatment widespread bacterial infections originating from the skin
systemic antibiotics that are active against staph aureus and steptococcus e..g flucloxacillin
localised clinical infection of the skin treatment
Topical antibiotics, including those combined with topical corticosteroids
antibiotics to cover staph aureus and strep
flucloxacillin
erythromycin in fluclox allergy/resistance
3 rd line clarithromycin
when are Antiseptics such as triclosan or chlorhexidine used in skin infection
Adjunct therapy for decreasing bacterial load in cases of recurrent infected atopic eczema
complications of eczema herpeticum if untreated
Encephalitis; particularly if on immunosuppressants
Hepatitis
Pneumonitis
what microorgansmism are resident on the skin
mainly gram positive cocci which are aerobic
- staph aureus
- staph epidermis
- strep species
some anaerobic gram positive bacilli
main gene involved in eczema
fillagrin gene - loss of function mutations strongly linked to eczema
pathology of eczema
breakdown in skin barrier function and inflammation primarily involving Th2 helper cells
emollient regime
for eczema; emollient moisturiser, shower gel, bath additive
emollient regimes reduce the need for topical steroids
topical corticosteroids in eczema
steroids are second line treatment in atopic eczema not controlled by emollient regime
potency should align with severity i.e. mild potency for mild eczema and increase with severity
shouldn’t be used for longer than 14 days for flares
only mild potency to be used on the face
applied once or twice a day
topical calcineurin inhibitors
Tacrolimus and Pimecrolimus are used in eczema as they suppress T-lymphocyte responses, thereby suppressing the synthesis of pro-inflammatory cytokines
used second line after emollients where steroids are wished to be avoided or try after steroids
only in moderate or severe eczema and over 2 years old
side-effect of burning/stinging sensation on initial application
stepwise treatment of eczema
- topical emollient regime
- topical corticosteroids / immune modulators
- phototherapy
- systemic treatments e..g azathioprine, cyclosporin
- biologic drugs e.g. Dupilumab (injection) and other oral agents which are JAK1 and JAK2 inhibitors
macules
flat lesions <5mm
papules
raised bumps <1cm
pustules
pus filled lesions less than 5mm
vesicles
fluid filled lesions less than 5mm
plaques
raised lesions greater than 1cm in size
features of psoriatic nails
pitting
onychylosis
subungal hyperkeratosis
periungal erythema
types of psoriasis
Generalsied pustular psoriasis
Chronic plaque psoriasis
Erythrodermic psoriasis
Guttate psoriasis
Flexural psoriasis
guttate psoriasis
small pink plaques of psoriasis seen on the trunk, often after a streptococcal sore throat
about 1/3 go on to have chronic plaque psoriasis
flexural psoriasis
psoriasis affecting the genitalia or axillae
Usually the appearance is red (erythematous) and slightly shiny, but there will still be a clearly defined edge between normal and affected skin
erythrodermic psoriasis
flare up/inflammation of psoriasis
When it covers over 90% of the body surface it is described as erythroderma. The skin is red, feels hot and even painful.
There may no longer be clearly defined plaques. Patients can feel unwell and become hypotensive. These patients should be admitted to hospital for treatment.
chronic plaque psoriasis
40% of presentations
typical distribution:
elbows and knees
nails
scalp
genitalia and natal cleft
Generalised Pustular Psoriasis
psoriasis can flare, become red, hot, painful and develop pustules within the plaques
emergency requiring hospital admission. The trigger is often WITHDRAWAL of use of a superpotent topical or systemic corticosteroids
psoriatic arthropathy
Between 5- 20% of patients with psoriasis have arthropathy affecting their joints. Arthropathy can precede (50%) or post-date (15%) the development of skin lesions. The patterns of arthropathy fall into five subtypes:
-distal interphalangeal alone
-symmetrical polyarthritis (commonest)
-asymmetrical oligoarthritis
-arthritis mutilans
-spondyloarthropathy
triggers/risk factors for psoriasis
family history
psychological stress
medications; antimalarial, NSAIDs, beta blockers, lithium
alcohol
management of psoriasis stepwise
emollients for all + reduce alcohol and smoking and lose weight
1st line: a potent corticosteroid applied once daily plus vitamin D analogue applied once daily (applied different times of day)
2nd line: if no improvement after 8 weeks a vitamin D analogue twice daily
3rd line: a potent corticosteroid applied twice daily for up to 4 weeks, or
a coal tar preparation applied once or twice daily
short-acting dithranol can also be used
phototherapy and systemic therapy can be considered by secondary care
biologics last step
cells involved in pathogenesis of psoriasis
Th1 cells
increased rate of keratinocyte proliferation
inflammatory angiogenesis
TNF-a and Psors genes also involved